Results 221 to 230 of about 43,499 (244)
Some of the next articles are maybe not open access.

Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer

Oral Oncology, 2014
Poly (ADP-ribose) polymerase inhibitors (PARPi) have shown single agent activity against tumors with deficiencies in the DNA repair mechanism homologous recombination including, but not limited to those harboring BRCA mutations. We hypothesized that, in the context of homologous recombination deficiency (HRD), PARPi could have an effect in head and ...
Jana Heitmann   +6 more
openaire   +2 more sources

Poly(ADP-ribose) polymerase (PARP) and PARP inhibitors

Drug Discovery Today: Disease Models, 2012
PARP-1 protects cells from endogenous and therapeutically inflicted DNA damage. PARP inhibitors have been under development since 1980 and first entered clinical trial in 2003. They are an exciting new class of drugs that have the potential to increase the efficacy of anticancer DNA damaging agents and to selectively target cells that have defects in ...
openaire   +2 more sources

A Review on Poly (ADP-ribose) Polymerase (PARP) Inhibitors and Synthetic Methodologies

Current Medicinal Chemistry, 2021
Ying Li, Chen-Fu Liu, Guo-Wu Rao
exaly  

Targeting angiogenesis with poly(ADP-ribose) polymerase inhibitors

2007
The process of angiogenesis is mediated by a wide range of factors, including pro-inflammatory cytokines. On the basis of the involvement of inflammation in tumor development and of the dual role of PARP inhibitor as enhancer of chemotherapy or as anti-inflammatory agent we have investigated the ability of PARP inhibitors to affect endothelial ...
MUZI, ALESSIA   +9 more
openaire   +1 more source

Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer

The Cochrane Library, 2022
Neil A J Ryan, Jo Morrison
exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap   +2 more
exaly  

PARP Inhibitors (Poly(ADP-Ribose) Polymerase Inhibitors)

2013
Larry C. Daugherty   +117 more
openaire   +1 more source

Home - About - Disclaimer - Privacy